Epigenetic Biomarkers in Cancer Detection and Diagnosis

Toxicology and Epigenetics

Volumn , Issue , 2012, Pages 317-338

  Rivenbark, Ashley G ^a   Coleman, William B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer epigenetics, governing uncontrolled cellular proliferation; Diagnostic tests and epigenetic biomarkers, determining cancer risk; DNA methylation and gene silencing in cancer; DNA methylation of epigenetic, and molecular assays; DNA methylation on cytosines, within CpG dinucleotides; DNA methylation, hallmark of epigenetic modifications; DNA methylation mediated regulation of transcription; DNMTs, catalyzing addition of methyl groups onto cytosine; Epigenetic biomarkers in cancer detection diagnosis; Genes commonly methylated in multiple human cancers

Indexed keywords

EID: 84887173097     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118349045.ch16     Document Type: Chapter

References (150)

1. Abe, M., Westermann, F., Nakagawara, A. et al. (2007) Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas. Cancer Lett., 247 (2), 253-258.
2. Araujo, F.D., Knox, J.D., Szyf, M. et al. (1998) Concurrent replication and methylation at mammalian origins of replication. Mol. Cell. Biol., 18 (6), 3475-3482.
3. Bae, Y.K., Brown, A., and Garrett, E. (2004) Hypermethylation in histologically distinct classes of breast cancer. Clin. Cancer Res., 10 (18, Pt. 1), 5998-6005.
4. Bai, A.H., Tong, J.H., To, K.F. et al. (2004) Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int. J. Cancer, 112 (5), 846-853.
5. Balch, C., Huang, T.H., Brown, R., and Nephew, K.P. (2004) The epigenetics of ovarian cancer drug resistance and resensitization. Am. J. Obstet. Gynecol., 191 (5), 1552-1572.
6. Baylin, S. (2001) DNA methylation and epigenetic mechanisms of carcinogenesis. Dev. Biol. (Basel), 106, 85-87.
7. Baylin, S.B. (2005) DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol., 2 (Suppl. 1), S4-11.
8. Baylin, S.B., Herman, J.G., Graff, J.R. et al. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196.
9. Baylin, S.B. and Ohm, J.E. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer, 6 (2), 107-116.
10. Belinsky, S.A., Grimes, M.J., Casas, E. et al. (2007) Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br. J. Cancer, 96 (8), 1278-1283.
11. Belinsky, S.A., Klinge, D.M., Dekker, J.D. et al. (2005) Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin. Cancer Res., 11 (18), 6505-6511.
12. Belinsky, S.A., Nikula, K.J., Palmisano, W.A. et al. (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. U.S.A., 95 (20), 11891-11896.
13. Belshaw, N.J., Elliott, G.O., Williams, E.A. et al. (2004) Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 13 (9), 1495-1501.
14. Bird, A.P. (1986) CpG-rich islands and the function of DNA methylation. Nature, 321, 209-213.
15. Bishop, J.M. (1991) Molecular themes in oncogenesis. Cell, 64 (2), 235-248.
16. Bosch, F.X., Ribes, J., Diaz, M., and Cleries, R. (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127 (5, Suppl. 1), S5-S16.
17. Cairns, P., Esteller, M., Herman, J.G. et al. (2001) Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res., 7 (9), 2727-2730.
18. Chen, W.D., Han, Z.J., Skoletsky, J. et al. (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J. Natl. Cancer Inst., 97 (15), 1124-1132.
19. Chen, Y., Huhn, D., Knosel, T. et al. (2005) Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int. J. Cancer, 113 (1), 14-21.
20. Claus, R., Almstedt, M., and Lubbert, M. (2005) Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin. Oncol., 32 (5), 511-520.
21. Compton, C., Fenoglio-Preiser, C.M., Pettigrew, N., and Fielding, L.P. (2000) American Joint Committee on Cancer prognostic factors consensus conference: Colorectal Working Group. Cancer, 88 (7), 1739-1757.
22. Costa, V.L., Henrique, R., and Jeronimo, C. (2007) Epigenetic markers for molecular detection of prostate cancer. Dis. Markers, 23 (1-2), 31-41.
23. Cottrell, S.E. (2004) Molecular diagnostic applications of DNA methylation technology. Clin. Biochem., 37 (7), 595-604.
24. Cottrell, S.E., Distler, J., Goodman, N.S. et al. (2004) A real-time PCR assay for DNA-methylation using methylationspecific blockers. Nucleic Acids Res., 32 (1), e10.
25. Cottrell, S.E. and Laird, P.W. (2003) Sensitive detection of DNA methylation. Ann. N. Y. Acad. Sci., 983, 120-130.
26. Cross, S.H., Meehan, R.R., Nan, X., and Bird, A. (1997) A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat. Genet., 16 (3), 256-259.
27. Dacic, S. (2007) Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis. Expert Rev. Mol. Diagn., 7 (1), 77-86.
28. Dammann, R., Schagdarsurengin, U., Seidel, C. et al. (2005) The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol. Histopathol., 20 (2), 645-663.
29. Dammann, R., Takahashi, T., and Pfeifer, G.P. (2001) The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene, 20 (27), 3563-3567.
30. Dammann, R., Yang, G., and Pfeifer, G.P. (2001) Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res., 61(7), 3105-3109.
31. Debinski, W., Gibo, D., and Mintz, A. (2003) Epigenetics in high-grade astrocytomas: opportunities for prevention and detection of brain tumors. Ann. N.Y. Acad. Sci., 983, 232-242.
32. Domann, F.E., Rice, J.C., Hendrix, M.J., and Futscher, B.W. (2000) Epigenetic silencing of maspin gene expression in human breast cancers. Int. J. Cancer, 85 (6), 805-810.
33. Donson, A.M., Addo-Yobo, S.O., Handler, M.H. et al. (2007) MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr. Blood Cancer, 48 (4), 403-407.
34. van Doorn, R., Gruis, N.A., Willemze, R. et al. (2005) Aberrant DNA methylation in cutaneous malignancies. Semin. Oncol., 32 (5), 479-487.
35. Du, Y., Carling, T., Fang, W. et al. (2001) Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res., 61 (22), 8094-8099.
36. Ducasse, M. and Brown, M.A. (2006) Epigenetic aberrations and cancer. Mol. Cancer, 5, 60.
37. Duenas-Gonzalez, A., Lizano, M., Candelaria, M. et al. (2005) Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol. Cancer, 4, 38.
38. Eads, C.A., Danenberg, K.D., Kawakami, K. et al. (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res., 59 (10), 2302-2306.
39. Eads, C.A., Danenberg, K.D., Kawakami, K. et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res., 28 (8), E32.
40. Eden, A., Gaudet, F., Waghmare, A., and Jaenisch, R. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300 (5618), 455.
41. Fackler, M.J., McVeigh, M., Evron, E. et al. (2003) DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int. J. Cancer, 107 (6), 970-975.
42. Feinberg, A.P. (2004) The epigenetics of cancer etiology. Semin. Cancer Biol., 14 (6), 427-432.
43. Feinberg, A.P. and Vogelstein, B. (1983a) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 301 (5895), 89-92.
44. Feinberg, A.P. and Vogelstein, B. (1983b) Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun., 111 (1), 47-54.
45. Feinberg, A.P. and Vogelstein, B. (1987) Alterations in DNA methylation in human colon neoplasia. Semin. Surg. Oncol., 3 (3), 149-151.
46. Fleischhacker, M. and Schmidt, B. (2007) Circulating nucleic acids (CNAs) and cancer-a survey. Biochim. Biophys. Acta, 1775 (1), 181-232.
47. Frommer, M., McDonald, L.E., Millar, D.S. et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U.S.A., 89 (5), 1827-1831.
48. Fukasawa, M., Kimura, M., Morita, S. et al. (2006) Microarray analysis of promoter methylation in lung cancers. J. Hum. Genet., 51 (4), 368-374.
49. Gardiner-Garden, M. and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196 (2), 261-282.
50. Gaudet, F., Hodgson, J.G., Eden, A. et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300 (5618), 489-492.
51. Gitan, R.S., Shi, H., Chen, C.M. et al. (2002) Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res., 12 (1), 158-164.
52. Goelz, S.E., Vogelstein, B., Hamilton, S.R., and Feinberg, A.P. (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science, 228 (4696), 187-190.
53. Goessl, C., Krause, H., Muller, M. et al. (2000) Fluorescent methylation-specific polymerase chain reaction for DNAbased detection of prostate cancer in bodily fluids. Cancer Res., 60 (21), 5941-5945.
54. Goessl, C., Muller, M., Heicappell, R. et al. (2001) DNA-based detection of prostate cancer in urine after prostatic massage. Urology, 58 (3), 335-338.
55. Goll, M.G. and Bestor, T.H. (2005) Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem., 74, 481-514.
56. Gonzalgo, M.L., Liang, G., Spruck, C.H. III, et al. (1997) Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res., 57 (4), 594-599.
57. Gonzalgo, M.L., Pavlovich, C.P., Lee, S.M., and Nelson, W.G. (2003) Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Clin. Cancer Res., 9 (7), 2673-2677.
58. Grady, W.M., Rajput, A., Lutterbaugh, J.D., and Markowitz, S.D. (2001) Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res., 61 (3), 900-902.
59. Ha, P.K. and Califano, J.A. (2006) Promoter methylation and inactivation of tumour-suppressor genes in oral squamouscell carcinoma. Lancet Oncol., 7 (1), 77-82.
60. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100 (1), 57-70.
61. Hayashizaki, Y., Hirotsune, S., Okazaki, Y. et al. (1993) Restriction landmark genomic scanning method and its various applications. Electrophoresis, 14 (4), 251-258.
62. Herath, N.I., Leggett, B.A., and MacDonald, G.A. (2006) Review of genetic and epigenetic alterations in hepatocarcinogenesis. J. Gastroenterol. Hepatol., 21 (1, Pt 1), 15-21.
63. Herman, J.G. and Baylin, S.B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med., 349, 2042-2054.
64. Hoque, M.O., Feng, Q., Toure, P. et al. (2006) Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J. Clin. Oncol., 24 (26), 4262-4269.
65. Hoque, M.O., Topaloglu, O., Begum, S. et al. (2005) Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J. Clin. Oncol., 23 (27), 6569-6575.
66. Huang, Z., Li, L., and Wang, J. (2007) Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig. Dis. Sci., 52, 2287-2291.
67. Huang, Z.H., Li, L.H., Yang, F., and Wang, J.F. (2007) Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J. Gastroenterol., 13 (6), 950-954.
68. Huang, T.H., Perry, M.R., and Laux, D.E. (1999) Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet., 8 (3), 459-470.
69. Jahr, S., Hentze, H., Englisch, S. et al. (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res., 61 (4), 1659-1665.
70. Jemal, A., Siegel, R., Ward, E. et al. (2007) Cancer statistics, 2007. CA Cancer J. Clin., 57 (1), 43-66.
71. Jeronimo, C., Usadel, H., Henrique, R. et al. (2002) Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology, 60 (6), 1131-1135.
72. Jhaveri, M.S. and Morrow, C.S. (1998) Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene, 210 (1), 1-7.
73. Johnson, P.J. and Lo, Y.M. (2002) Plasma nucleic acids in the diagnosis and management of malignant disease. Clin. Chem., 48 (8), 1186-1193.
74. Jones, P.A. (1999) The DNA methylation paradox. Trends Genet., 15 (1), 34-37.
75. Jones, P.A. and Laird, P.W. (1999) Cancer epigenetics comes of age. Nat. Genet., 21 (2), 163-167.
76. Jones, P.A. and Takai, D. (2001) The role of DNA methylation in mammalian epigenetics. Science, 293, 1068-1070.
77. Kay, P.H., Spagnolo, D.V., Taylor, J., and Ziman, M. (1997) DNA methylation and developmental genes in lymphomagenesis-more questions than answers? Leuk. Lymphoma, 24 (3-4), 211-220.
78. Kerr, K.M., Galler, J.S., Hagen, J.A. et al. (2007) The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis. Markers, 23 (1-2), 5-30.
79. Kondo, Y. and Issa, J.P. (2004) Epigenetic changes in colorectal cancer. Cancer Metastasis Rev., 23 (1-2), 29-39.
80. Konishi, N., Shimada, K., Ishida, E., and Nakamura, M. (2005) Molecular pathology of prostate cancer. Pathol. Int., 55 (9), 531-539.
81. Krassenstein, R., Sauter, E., Dulaimi, E. et al. (2004) Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin. Cancer Res., 10 (1, Pt 1), 28-32.
82. Kuroki, T., Tajima, Y., and Kanematsu, T. (2004) Role of hypermethylation on carcinogenesis in the pancreas. Surg. Today, 34 (12), 981-986.
83. Lai, J.C., Cheng, Y.W., Chiou, H.L. et al. (2005) Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer. Int. J. Cancer, 117 (6), 974-980.
84. Laird, P.W. (2003) The power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3 (4), 253-266.
85. Lenhard, K., Bommer, G.T., Asutay, S. et al. (2005) Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin. Gastroenterol. Hepatol., 3 (2), 142-149.
86. Leung, W.K., To, K.F., Man, E.P. et al. (2004) Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer: a feasibility study. Clin. Chem., 50 (11), 2179-2182.
87. Leung, W.K., To, K.F., Man, E.P. et al. (2005) Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am. J. Gastroenterol., 100 (10), 2274-2279.
88. Leung, W.K., To, K.F., Man, E.P. et al. (2007) Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am. J. Gastroenterol., 102 (5), 1070-1076.
89. Lewis, J.D., Meehan, R.R., Henzel, W.J. et al. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69 (6), 905-914.
90. Lin, I.G., Han, L., Taghva, A. et al. (2002) Murine de novo methyltransferase Dnmt3a demonstrates strand asymmetry and site preference in the methylation of DNA in vitro. Mol. Cell. Biol., 22 (3), 704-723.
91. Liu, Y., Lan, Q., Siegfried, J.M. et al. (2006) Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia, 8 (1), 46-51.
92. Lynch, J.P. and Hoops, T.C. (2002) The genetic pathogenesis of colorectal cancer. Hematol. Oncol. Clin. North Am., 16 (4), 775-810.
93. McGlynn, K.A. and London, W.T. (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract. Res. Clin. Gastroenterol., 19 (1), 3-23.
94. McLoughlin, R.M. and O'Morain, C.A. (2006) Colorectal cancer screening. World J. Gastroenterol., 12 (42), 6747-6750.
95. Meehan, R.R., Lewis, J.D., McKay, S. et al. (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58 (3), 499-507.
96. Mielnicki, L.M., Asch, H.L., and Asch, B.B. (2001) Genes, chromatin, and breast cancer: an epigenetic tale. J. Mammary Gland Biol. Neoplasia, 6 (2), 169-182.
97. Miyamoto, K., Asada, K., Fukutomi, T. et al. (2003) Methylation-associated silencing of heparan sulfate Dglucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene, 22 (2), 274-280.
98. Miyamoto, K. and Ushijima, T. (2005) Diagnostic and therapeutic applications of epigenetics. Jpn. J. Clin. Oncol., 35 (6), 293-301.
99. Momparler, R.L. (2003) Cancer epigenetics. Oncogene, 22 (42), 6479-6483.
100. Muller, H.M., Oberwalder, M., Fiegl, H. et al. (2004) Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet, 363 (9417), 1283-1285.
101. Muller, H.M., Widschwendter, A., Fiegl, H. et al. (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res., 63 (22), 7641-7645.
102. Nakayama, H., Hibi, K., Taguchi, M. et al. (2002) Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett., 188 (1-2), 115-119.
103. Nakayama, H., Hibi, K., Takase, T. et al. (2003) Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int. J. Cancer, 105 (4), 491-493.
104. Narayan, A., Ji, W., Zhang, X.Y. et al. (1998) Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer, 77 (6), 833-838.
105. Osada, H., Tatematsu, Y., Yatabe, Y. et al. (2002) Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene, 21 (15), 2418-2424.
106. Palmisano, W.A., Divine, K.K., Saccomanno, G. et al. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60 (21), 5954-5958.
107. Paluszczak, J. and Baer-Dubowska, W. (2006) Epigenetic diagnostics of cancer-the application of DNA methylation markers. J. Appl. Genet., 47 (4), 365-375.
108. Paulsen, M., Tierling, S., and Walter J. (2008) DNA methylation and the mammalian genome, in Epigenetics (ed. J. Tost), Caister Academic Press, Norfolk, pp. 1-21.
109. Perry, A.S., Foley, R., Woodson, K., and Lawler, M. (2006) The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr. Relat. Cancer, 13 (2), 357-377.
110. Petko, Z., Ghiassi, M., Shuber, A. et al. (2005) Aberrantly methylated CDKN2A, MGMT, and MLH1in colon polyps and in fecal DNA from patients with colorectal polyps. Clin. Cancer Res., 11 (3), 1203-1209.
111. Pfeifer, G.P. and Dammann, R. (2005) Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc), 70 (5), 576-583.
112. Pradhan, S., Bacolla, A., Wells, R.D., and Roberts, R.J. (1999) Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem., 274 (46), 33002-33010.
113. Ramirez, J.L., Sarries, C., de Castro, P.L. et al. (2003) Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Lett., 193 (2), 207-216.
114. Razin, A. and Riggs, A.D. (1980) DNA methylation and gene function. Science, 210, 604-610.
115. Razin, A. and Szyf, M. (1984) DNA methylation patterns. Formation and function. Biochim. Biophys. Acta, 782, 331-342.
116. Rivenbark, A.G., Jones, W.D., and Coleman, W.B. (2006) DNA methylation-dependent silencing of CST6 in human breast cancer cell lines. Lab. Invest., 86, 13 3-1242.
117. Rivenbark, A.G., Jones, W.D., Risher, J.D., and Coleman, W.B. (2006) DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells. Epigenetics, 1 (1), 32-44.
118. Rivenbark, A.G., Livasy, C.A., Boyd, C.E. et al. (2007) Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. Exp. Mol. Pathol., 83 (2), 188-197.
119. Roupret, M., Hupertan, V., Yates, D.R. et al. (2007) Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin. Cancer Res., 13 (6), 1720-1725.
120. Sanchez-Cespedes, M., Decker, P.A., Doffek, K.M. et al. (2001) Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res., 61 (5), 2092-2096.
121. Shapiro, G.I., Park, J.E., Edwards, C.D. et al. (1995) Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res., 55 (24), 6200-6209.
122. Sharma, G., Mirza, S., Prasad, C.P. et al. (2007) Promoter hypermethylation of p16(INK4A), p14(ARF), CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci., 80 (20), 1873-1881.
123. Soria, J.C., Rodriguez, M., Liu, D.D. et al. (2002) Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res., 62 (2), 351-355.
124. Suh, C.I., Shanafelt, T., May, D.J. et al. (2000) Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Mol. Cell. Probes, 14 (4), 211-217.
125. Takai, D. and Jones, P.A. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. U.S.A., 99, 3740-3745.
126. Tanaka, R., Wang, D., Morishita, Y. et al. (2005) Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma. Cancer, 103 (3), 608-615.
127. Thorgeirsson, S.S. and Grisham, J.W. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet., 31 (4), 339-346.
128. Tlsty, T.D., Crawford, Y.G., Holst, C.R. et al. (2004) Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J. Mammary Gland Biol. Neoplasia, 9 (3), 263-274.
129. Toyooka, S., Toyooka, K.O., Maruyama, R. et al. (2001) DNA methylation profiles of lung tumors. Mol. Cancer Ther., 1 (1), 61-67.
130. Toyota, M., Ho, C., Ahuja, N. et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 59 (10), 2307-2312.
131. Tsou, J.A., Hagen, J.A., Carpenter, C.L., and Laird-Offringa, I.A. (2002) DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene, 21 (35), 5450-5461.
132. Tsou, J.A., Shen, L.Y., Siegmund, K.D. et al. (2005) Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer, 47 (2), 193-204.
133. Van Emburgh B.O. and Robertson K.D. (2008) DNA methyltranferases and methyl-CpG binding proteins as multifunctional regulators of chromatin structure and development in mammalian cells, in Epigenetics (ed. J. Tost), Caister Academic Press, Norfolk.
134. Wallner, M., Herbst, A., Behrens, A. et al. (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin. Cancer Res., 12 (24), 7347-7352.
135. Weinberg, R.A. (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res., 49 (14), 3713-3721.
136. Widschwendter, M. and Jones, P.A. (2002) DNA methylation and breast carcinogenesis. Oncogene, 21 (35), 5462-5482.
137. Wistuba, I.I., Gazdar, A.F., and Minna J.D. (2001) Molecular genetics of small cell lung carcinoma. Semin. Oncol., 28 (2, Suppl. 4), 3-13.
138. Wong, I.H., Lo, Y.M., Yeo, W. et al. (2000) Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin. Cancer Res., 6 (9), 3516-3521.
139. Wong, I.H., Lo, Y.M., Zhang, J. et al. (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res., 59 (1), 71-73.
140. Xu, X.L., Wu, L.C., Du, F. et al. (2001) Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res., 61 (21), 7943-7949.
141. Yan, P.S., Venkataramu, C., Ibrahim, A. et al. (2006) Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin. Cancer Res., 12 (22), 6626-6636.
142. Yen, R.W., Vertino, P.M., Nelkin, B.D. et al. (1992) Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res., 20 (9), 2287-2291.
143. Yeo, W., Wong, N., Wong, W.L. et al. (2005) High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Liver Int., 25 (2), 266-272.
144. Yokochi, T. and Robertson, K.D. (2002) Preferential methylation of unmethylated DNA by Mammalian de novo DNA methyltransferase Dnmt3a. J. Biol. Chem., 277 (14), 11735-11745.
145. Zhang, Y.J., Wu, H.C., Shen, J. et al. (2007) Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin. Cancer Res., 13 (8), 2378-2384.
146. Zhu, J. (2006) DNA methylation and hepatocellular carcinoma. J. Hepatobiliary Pancreat. Surg., 13 (4), 265-273.
147. Zhu, W.G., Srinivasan, K., Dai, Z. et al. (2003) Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol. Cell. Biol., 23 (12), 4056-4065.
148. Zhu, J. and Yao, X. (2007) Use of DNA methylation for cancer detection and molecular classification. J. Biochem. Mol. Biol., 40 (2), 135-141.
149. Ziegler, A., Zangemeister-Wittke, U., and Stahel, R.A. (2002) Circulating DNA: a new diagnostic gold mine? Cancer Treat. Rev., 28 (5), 255-271.
150. Zou, H.Z., Yu, B.M., Wang, Z.W. et al. (2002) Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8 (1), 188-191.